Develops precision medicines for neurodegenerative diseases such as ALS and frontotemporal dementia (FTD) using its antisense oligonucleotide splice modulator platform.
QurAlis Europe
Details
- LSH Companies
Bargelaan 200, 2333 CW, Leiden
Develops precision medicines for neurodegenerative diseases such as ALS and frontotemporal dementia (FTD) using its antisense oligonucleotide splice modulator platform.
Bargelaan 200, 2333 CW, Leiden